Industry-leading weight loss without medications
Navigating type 2 diabetes and obesity in the world of GLP-1s
Weight loss medication use and costs are skyrocketing. Virta can help.
GLP-1 use, both on- and off-label, has led to surging Rx costs for payers, and even medication shortages for people who truly need them.
GLP-1s are effective but expensive and still require lifestyle changes
Traditional diet and exercise programs are unsuccessful in helping maintain weight loss
Costs are rising 2-4x for GLP-1 drug class alone
A better way to navigate GLP-1 costs and utilization
Current GLP-1 strategies fall into three categories: easy access, gatekeeper with prior authorization and step therapy, and combo therapy with traditional diet and exercise.
Virta offers new options to manage GLP-1 utilization while protecting access for those who need it.
An alternative to GLP-1s
A sustainable GLP-1 offramp
Comparable weight loss to GLP-1s at a fraction of the cost
Virta is a leading virtual clinic that reverses type 2 diabetes, obesity, and prediabetes. Our members lose weight—while reducing dependence on GLP-1s and other medications—and experience long-lasting results at a fraction of the cost of pharmaceutical or surgical treatments.
12%
A proven approach for deprescribing GLP-1s
Virta aims to deprescribe diabetes and obesity medications (including GLP-1s) for everyone in whom it is safe to do so
- Health coaches support members in making nutritional changes.
- Members lose weight and feel better.
- Virta providers deprescribe GLP-1s and other medications based on rigorous clinical protocols.
- Members sustain weight loss progress.
4 in 5 executives are significantly concerned about GLP-1 growth
Find out why Chief Medical Officers, Chief Pharmacy Officers and actuarial leaders are significantly concerned about GLP-1 utilization and cost growth and why they expect this crisis to last the rest of the decade.
Read the report
Life-changing weight loss that lasts
Dan lost 110 pounds and changed his attitude
Benefits leader Sheri knows Virta works first hand
DeShawn is breaking his family history of diabetes
Ready to learn more?
- Hallberg SJ et al. Diabetes Therapy. 2018;9(2):583-612 and Bhanpuri NH et al. Cardiovasc Diabetol. 2018; 17:56.